Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) FCF Margin (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed FCF Margin for 2 consecutive years, with 6017.53% as the latest value for Q1 2024.

  • Quarterly FCF Margin changed N/A to 6017.53% in Q1 2024 from the year-ago period, while the trailing twelve-month figure was 22180.88% through Dec 2024, changed N/A year-over-year, with the annual reading at 22180.88% for FY2024, 2203921.0% down from the prior year.
  • FCF Margin for Q1 2024 was 6017.53% at Artiva Biotherapeutics, down from 428.77% in the prior quarter.
  • The five-year high for FCF Margin was 42.39% in Q3 2023, with the low at 6017.53% in Q1 2024.